Name: George Solar
Phone Number: (747) 216-2988

FOR IMMEDIATE RELEASE – April 7, 2026 – Los Angeles, California – Megalodon

Distribution LLC has voluntarily recalled 2 lots of DFT Sexual Chocolate, 2 doses per chocolate bar from the retail level. Per the FDA, DFT Sexual Chocolate has been found to contain sildenafil and tadalafil not listed on the product’s packaging.

Risk Statement: Per the FDA, sildenafil and tadalafil potentially could interact with nitrates found in some prescription drugs, such as nitroglycerin, and may lower blood pressure to a dangerous level. Per the FDA, people with diabetes, high blood pressure, high cholesterol or heart disease often take nitrates. Megalodon Distribution LLC has not received any reports of adverse events related to this recall.

DFT Sexual Chocolate is used to enhance sexual performance and is packaged in a mylar pouch, in 20 count displays, ITEM#DTF10013. The affected DFT Sexual Chocolate lots include the following lot numbers and expiration dates: LOT 20241022 EXP 12/31/27 and LOT 20250318 EXP 12/31/28. DFT Sexual Chocolate can be identified by users by UPC CODE 757817783137. DFT Sexual Chocolate was distributed Nationwide to retail outlets.

Megalodon Distribution LLC has notified its retailers by email and has arranged for the return or destruction of DFT Sexual Chocolate. Retailers that still have DFT Sexual Chocolate should either return it to Megalodon Distribution LLC or discard.

Retailers with questions regarding this recall may contact Megalodon Distribution LLC by (747) 216-2988 or DTFrecall@gmail.com on Monday through Friday from 9:00 am to 5:00 p.m. PT.

Consumers may contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using DFT Sexual Chocolate. Adverse reactions or quality problems experienced with the use of DFT Sexual Chocolate may be reported to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail or by fax. Complete and submit the report by:

Online: www.fda.gov/medwatch/report.htm
Regular Mail or Fax: Download form www.fda.gov/MedWatch/getforms.htm or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178.

This recall has been conducted with the knowledge of the U.S. Food and Drug Administration.